Overview
- 116 inspections across 92 sites are on record.
- 289 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2024-05-29.
At a glance
Inspections
116
Sites
92
Observations
289
Career since
Mar 2009
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Olympia Pharmaceuticals | 29 May 2024 | Human Drugs | View 483 → |
| Abbvie LTD | 18 Apr 2024 | Human Drugs | View 483 → |
| Baxter Healthcare Corporation | 9 Feb 2024 | Human Drugs | View 483 → |
| SGS Canada Inc | 15 Nov 2023 | Human Drugs | |
| Resilience Biotechnologies, Inc. | 10 Nov 2023 | Human Drugs | View 483 → |
Sites inspected
Olympia PharmaceuticalsOrlando, United States1 insp.
Abbvie LTDBarceloneta, United States1 insp.
Baxter Healthcare CorporationMarion, United States1 insp.
SGS Canada IncMississauga, Canada1 insp.
Resilience Biotechnologies, Inc.Mississauga, Canada1 insp.
Co-investigators
Investigators who share inspections with this person.
Jose A Lopez Rubet3 shared
Raquel Gonzalez Rivera3 shared
Jose F Velez2 shared
Dennis Cantellops Paite2 shared
Xiaokuang Lai2 shared
Brian J Ryan2 shared
Jose E Melendez2 shared
Jose R Lopez2 shared
Stephen D Brown2 shared
Jessica P Mcalister1 shared
Full investigator report
Get the verbatim findings behind Libia M Lugo's 289 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site